Immunotherapy has become one of the most promising approaches in tumor therapy, and there are numerous associated clinical trials China. As an immunosuppressive tumor, head neck squamous cell carcinoma (HNSCC) carries a high mutation burden, making immune checkpoint inhibitors candidates this field due to their unique mechanism action. The present review outlines comprehensive multidisciplinary...

Tumor-associated fibroblasts (CAFs) are a significant component of the tumor microenvironment (TME) head and neck squamous cell carcinoma (HNSCC) may stimulate their progression, although exact mechanisms not well understood. This work aimed to establish biologically relevant HNSCC model as basis for further investigations.

PURPOSE Head and neck squamous cell carcinoma (HNSCC) represents the eighth most common malignancy worldwide. Standard-of-care treatments for patients with HNSCC include surgery, radiation, and chemotherapy. In addition, the anti-EGFR monoclonal antibody cetuximab is often used in combination with these treatment modalities. Despite clinical success with these therapeutics, HNSCC remains a diff...

Background/Aim: Prognosis plays a vital role in head and neck squamous cell carcinoma (HNSCC) patient management decision-making. This study aimed to identify the of BP180 as prognostic factor HNSCC. Patients Methods: Protein expression bullous pemphigoid antigen II (BP180) was verified by immunohistochemistry (IHC) tissue microarray 202 cases. Results: IHC analysis revealed that protein among ...

PURPOSE Head and neck squamous cell carcinoma (HNSCC) shows persistent invasion that frequently leads to local recurrence and distant lymphatic metastasis. However, molecular mechanisms associated with invasion of HNSCC remain poorly understood. We identified IFN-induced transmembrane protein 1 (IFITM1) as a candidate gene for promoting the invasion of HNSCC by comparing the gene expression pro...

To assess the role of transcription factor μE3 (TFE3) in the tumorigenesis of head and neck squamous cell carcinoma (HNSCC), human HNSCC tissue arrays were investigated for TFE3 expression. Human HNSCC tissues with neoadjuvant inductive chemotherapey (docetaxel, cisplatin and fluorouracil, TPF) and mice HNSCC tissues from transgenic mice model were evaluated for TFE3 expression and the hypoxia ...

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide associated with high mortality. The main reasons for treatment failure are a low rate of early diagnosis, relapse rates, distant metastasis poor outcomes. These largely due to lack diagnostic, prognostic, predictive biomarkers in HNSCC. DNA methylation has been demonstrated play an important role pathogenesi...

Fanconi anemia (FA) patients have an increased risk of head and neck squamous cell carcinoma (HNSCC) at a higher rate with no apparent risk factors. HNSCC of FA patients is an aggressive tumor characterized by multifocal origin, early metastases and frequent recurrences. Given that cancer stem cells (CSC) drive tumorigenesis, tumor recurrence and metastasis, in this study, we characterized the ...

The tumor microenvironment (TME) greatly influences the proliferation and progression of HNSCC. Hence, an in depth understanding vivo TME is crucial recapitulating like pathophysiology vitro, still remains a challenge. 3D bioprinted models are increasingly researched on due to their ability precisely replicate cellular organization as seen vivo. This project attempts HNSCC vitro via bio printin...

Head and neck squamous cell carcinoma (HNSCC) is one of the most common types of human cancer. Typically, HNSCC cells show persistent invasion that frequently leads to local recurrence and distant lymphatic metastasis. However, molecular mechanisms associated with the invasion and metastasis of HNSCC remain poorly understood. Here, we identified periostin as an invasion-promoting factor in HNSC...